XML 22 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Parent Company [Member]    
Cash flows from operating activities:    
Consolidated net income $ (65,958) $ (50,820)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization (123,082) (121,361)
(Gain) Loss on sale of depreciable real estate assets excluded from discontinued operations 13 0
Gain on sale of non-depreciable real estate assets (8,963) (150)
Stock compensation expense 4,785 4,024
Amortization of debt premium 1,747 (1,569)
Proceeds from Other Operating Activities (31,944) (21,782)
Net cash provided by operating activities 154,678 152,704
Cash flows from investing activities:    
Purchases of real estate and other assets (13,595) 0
Normal capital improvements (53,214) (51,775)
Proceeds from Equity Method Investment, Distribution, Return of Capital 43 0
Contributions to Real Estate Joint Ventures 0 (750)
Proceeds from disposition of real estate assets 13,882 5,860
Net cash (used in) provided by investing activities (52,884) (46,665)
Cash flows from financing activities:    
Proceeds from Lines of Credit 145,000 150,000
Repayments of Lines of Credit 610,000 110,000
Proceeds from notes payable 490,435 0
Principal payments on notes payable (1,847) (41,042)
Payment of deferred financing costs 4,705 0
Proceeds from Stock Options Exercised 200 600
Distributions to noncontrolling interests (3,947) (3,865)
Dividends paid on common shares (109,324) (104,876)
Dividends, Preferred Stock, Cash (922) (922)
Proceeds from (Payments for) Other Financing Activities 1,230 (2,091)
Net cash used in financing activities (94,080) (112,796)
Net (decrease) increase in cash and cash equivalents 7,714 (6,757)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning 51,673 88,867
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending 59,387 82,110
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 44,623 59,706
Restricted Cash 14,764 22,404
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending 59,387 82,110
Supplemental disclosure of cash flow information:    
Interest paid 18,322 24,889
Income Taxes Paid 59 2,522
Supplemental disclosure of noncash investing and financing activities:    
Conversion of units to shares of common stock 336 2,780
Accrued construction in progress 15,155 14,640
Interest capitalized 388 795
Marked To Market Adjustment On Derivative Instruments 3,633 (1,363)
Limited Partner [Member]    
Cash flows from operating activities:    
Consolidated net income (65,958) (50,820)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization (123,082) (121,361)
(Gain) Loss on sale of depreciable real estate assets excluded from discontinued operations 13 0
Gain on sale of non-depreciable real estate assets (8,963) (150)
Stock compensation expense 4,785 4,024
Amortization of debt premium 1,747 (1,569)
Proceeds from Other Operating Activities (31,944) (21,782)
Net cash provided by operating activities 154,678 152,704
Cash flows from investing activities:    
Purchases of real estate and other assets (13,595) 0
Normal capital improvements (53,214) (51,775)
Proceeds from Equity Method Investment, Distribution, Return of Capital 43 0
Contributions to Real Estate Joint Ventures 0 (750)
Proceeds from disposition of real estate assets 13,882 5,860
Net cash (used in) provided by investing activities (52,884) (46,665)
Cash flows from financing activities:    
Proceeds from Lines of Credit 145,000 150,000
Repayments of Lines of Credit 610,000 110,000
Proceeds from notes payable 490,435 0
Principal payments on notes payable (1,847) (41,042)
Payment of deferred financing costs 4,705 0
Distributions paid on common units (113,271) (108,741)
Dividends, Preferred Stock, Cash (922) (922)
Proceeds from (Payments for) Other Financing Activities 1,230 (2,091)
Net cash used in financing activities (94,080) (112,796)
Net (decrease) increase in cash and cash equivalents 7,714 (6,757)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning 51,673 88,867
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending 59,387 82,110
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 44,623 59,706
Restricted Cash 14,764 22,404
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending 59,387 82,110
Supplemental disclosure of cash flow information:    
Interest paid 18,322 24,889
Income Taxes Paid 59 2,522
Supplemental disclosure of noncash investing and financing activities:    
Accrued construction in progress 15,155 14,640
Interest capitalized 388 795
Marked To Market Adjustment On Derivative Instruments $ 3,633 $ (1,363)